3rd AFNET DGK Young Investigator Award – Atrial Fibrillation 2026

Once again, four young scientists were honored with the AFNET-sponsored “DGK AFNET Young Investigator Award” for their current research on atrial fibrillation. AFNET Board Member and this year’s DGK Conference President Prof. Dr. Stephan Willems congratulated the award recipients during the award ceremony on April 10, 2026 at the DGK Annual Congress.

3rd AFNET Lecture Award 2026

As part of the “23 Years of AFNET” session, Prof. Steinbeck presented the AFNET Lecture titled “EP Studies Revisited.” For his long-standing commitment, he received this year’s DGK-AFNET Lecture Award, which was presented for the third time. Prof. Sinner presented the results of the 10th AFNET-EHRA Consensus Conference.

DGK Heart Days 2026

The ESC Congress 2026 will take place from August 29 to September 1, 2026, in Munich, Germany, at the International Congress Center Munich (ICM).

ESC Congress 2026

The ESC Congress 2026 will take place from August 29 to September 1, 2026, in Munich, Germany, at the International Congress Center Munich (ICM).

SKY AF Summit

Unter der Schirmherrschaft von AFNET und DGK findet am 27. Mai 2026 der SKY AF Summit (Frankfurt am Main & online) statt – eine internationale wissenschaftliche Veranstaltung mit einem facettenreichen Programm.
Im Fokus stehen die jüngsten Fortschritte im Verständnis und in der Behandlung des Vorhofflimmerns.

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation

A prespecified analysis of the NOAH – AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in patients with device-detected atrial fibrillation. Today, the findings were presented by AFNET board member Prof. Andreas Goette, St. Vincenz Hospital, Paderborn, Germany, at the annual congress of the European Heart Rhythm Association (EHRA) in Paris and published in the EP Europace journal (1,2).

AF-B STEP: Global collaboration to reduce the burden of atrial fibrillation and advance quantification and treatment

Atrial fibrillation (AF) affects millions of people worldwide – yet the condition is rarely quantified upon diagnosis. The international research project AF-B-STEP aims to change this: for the first time, it will systematically assess how much time individuals spend in AF, expressed as their AF burden, and determine the extent to which the AF burden influences the risk of stroke, heart failure and other aspects of patients´ lives.